Dr David Stamler Appointed CEO
- Written by PR Newswire
MELBOURNE, Australia, Jan. 7, 2021 /PRNewswire/ -- The Board of Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") is pleased to announce the appointment of Dr David Stamler to the role of Chief Executive Office effective immediately.
Dr Stamler joined the Company in June 2017 as Chief Medical Officer and Senior Vice...